Idexx Laboratories | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Abbott USD 7.62B 58M 2024-12
Align Technology USD 1.04B 1.95M 2024-12
Dentsply International USD 272M 24M 2024-12
Dexcom USD 606.1M 15.1M 2024-12
Edwards Lifesciences USD 3.05B 631.2M 2024-12
Fujifilm JPY 216.25B 29.13B 2024-12
Globus Medical USD 784.44M 161.67M 2024-12
Henry Schein USD 122M 4M 2024-12
Hologic USD 1.78B 378.1M 2024-12
Idexx Laboratories USD 288.27M 20.37M 2024-12
Insulet USD 820M 133.5M 2024-12
Integra LifeSciences USD 246.38M 31.22M 2024-12
Intuitive Surgical USD 8.83B 6.42B 2024-12
Masimo USD 177.6M 19.1M 2024-12
Neogen USD 140.23M 19.75M 2024-11
Patterson Companies USD 135M 22.94M 2025-01
ResMed USD 521.94M 95.58M 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Steris USD 155.18M 17.02M 2024-12
Tandem Diabetes Care USD 69.23M 20.2M 2024-12
Teleflex USD 290.19M 46.95M 2024-12
Thermo Fisher Scientific USD 4.01B 636M 2024-12
Zoetis USD 1.98B 275M 2024-12



Idexx Laboratories Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.